Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Jul;32(7):861-72.
doi: 10.1038/aps.2011.68. Epub 2011 Jun 20.

CaMKII in cerebral ischemia

Affiliations
Review

CaMKII in cerebral ischemia

Steven J Coultrap et al. Acta Pharmacol Sin. 2011 Jul.

Abstract

Ischemic insults on neurons trigger excessive, pathological glutamate release that causes Ca²⁺ overload resulting in neuronal cell death (excitotoxicity). The Ca²⁺/calmodulin (CaM)-dependent protein kinase II (CaMKII) is a major mediator of physiological excitatory glutamate signals underlying neuronal plasticity and learning. Glutamate stimuli trigger autophosphorylation of CaMKII at T286, a process that makes the kinase "autonomous" (partially active independent from Ca²⁺ stimulation) and that is required for forms of synaptic plasticity. Recent studies suggested autonomous CaMKII activity also as potential drug target for post-insult neuroprotection, both after glutamate insults in neuronal cultures and after focal cerebral ischemia in vivo. However, CaMKII and other members of the CaM kinase family have been implicated in regulation of both neuronal death and survival. Here, we discuss past findings and possible mechanisms of CaM kinase functions in excitotoxicity and cerebral ischemia, with a focus on CaMKII and its regulation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Ischemic core and penumbra after stroke. While neurons in the ischemic core are considered beyond rescue, neurons in the penumbra are potential targets for therapeutic intervention.
Figure 2
Figure 2
The CaM kinase family tree, with a limited number of example CaM kinases marked.
Figure 3
Figure 3
CaMKII structure, and regulation. (A) CaMKII forms multimeric holoenzymes via C-terminal association domains (acqua). Each kinase domain (grey, dark blue) is stimulated separately by Ca2+/CaM binding, but intersubunit autophosphorylation at T286 generates autonomous activity that persists even after dissociation of Ca2+/CaM. (B) In the basal state, the regulatory α-helix (ribbon) interacts with the T-site (yellow) and prevents access to the substrate binding S-site (orange). Autophosphorylation sites (red) generate autonomous activity (T286) or prevent CaM binding (T305/306) and affect targeting. (C) The sequence of the regulatory α-helix. The regions contributing to CaM-binding and to auto-inhibition are marked.
Figure 4
Figure 4
CaMKII downstream targets that may be involved in regulation of neuronal viability. CaMKII signaling may promote excitotoxic cell death (red) or neuronal survival (green). Activation (arrow) or inhibition (bar) of the downstream targets is indicated. Some but not all of these downstream effects are mediated by direct phosphorylation of the target.

References

    1. Liu S, Levine SR, Winn HR. Targeting ischemic penumbra: part I – from pathophysiology to therapeutic strategy. J Exp Stroke Transl Med. 2010;3:47–55. - PMC - PubMed
    1. Weinberger JM. Evolving therapeutic approaches to treating acute ischemic stroke. J Neurol Sci. 2006;249:101–9. - PubMed
    1. Kaur J, Zhao Z, Klein GM, Lo EH, Buchan AM. The neurotoxicity of tissue plasminogen activator. J Cereb Blood Flow Metab. 2004;24:945–63. - PubMed
    1. Wang X, Tsuji K, Lee SR, Ning M, Furie KL, Buchan AM, et al. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke. 2004;35:2726–30. - PubMed
    1. Kleindorfer D, Lindsell CJ, Brass L, Koroshetz W, Broderick JP. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke. 2008;39:924–8. - PubMed

Publication types

MeSH terms

Substances